August 9, 2015 |
Twelve members of Congress have asked the U.S. Government Accountability Office to investigate why an electric device used in gynecologic surgery was marketed for two decades before safety warnings were issued by the Food and Drug Administration. The tissue-dissecting device, called a power morcellator, enables hysterectomies to be done through small rather than large abdominal incisions, but it can also spread and worsen an undetected uterine cancer. After that horrible scenario befell anesthesiologist Amy Reed at a Boston hospital in late 2013, she and her husband, heart surgeon Hooman Noorchashm, launched a campaign to ban electric morcellators.
March 6, 2015 |
Amy Reed, the doctor who has pushed for a ban on the gynecological surgery device that worsened her uterine cancer prognosis, said Wednesday that she is fighting a recurrence. Reed, 41, had about a year in apparent remission after her 2013 diagnosis and treatment for leiomyosarcoma, a rare and ferociously aggressive uterine cancer. Two weeks ago, she had surgery at the Hospital of the University of Pennsylvania to remove a small tumor that a scan revealed in the bony part of her spinal column.
February 21, 2015 |
The dangers of a power tool used in gynecological surgery have been debated for more than a year, with experts offering varying estimates of the chance that an undetected uterine cancer would be spread - and likely worsened - by the tissue-slicing device. Now, two new studies have waded into the controversy. Using a nationwide insurance claims database, Columbia University researchers looked at women treated for uterine growths called fibroids. Uterine cancer was discovered in one out of every 1,073 who underwent power morcellation, and one out of 528 without morcellation.
May 22, 2014 |
Two doctors' groups are defending a tissue-cutting device that makes gynecological surgery less invasive but in rare cases spreads a hidden uterine cancer. Electric morcellators, introduced in 1993, are used to dissect the uterus or uterine fibroids so tissue can be removed through small abdominal incisions. They have come under scrutiny in recent months because the motorized blade can disseminate bits of undetected cancer. Many hospitals have halted their use; the Food and Drug Administration last month issued a safety advisory "discouraging" power morcellation; and Johnson & Johnson suspended worldwide sales of its version of the machine.
April 1, 2014 |
The husband-and-wife doctors who have turned their personal tragedy into a public health crusade are getting traction. Cardiothoracic surgeon Hooman Noorchashm and his wife, anesthesiologist Amy Reed, 40 - both trained in Philadelphia and affiliated with Harvard Medical School - want electric tissue-cutting morcellators banned from gynecologic surgery. Power morcellation, introduced in 1993, enables tissue removal through tiny abdominal incisions, but in rare cases it can also spread a hidden uterine cancer called leiomyosarcoma.
March 19, 2014 |
The husband of a Berks County woman who died of a rare uterine cancer following a minimally invasive hysterectomy is suing the maker of the device used in her surgery at Reading Hospital. The lawsuit, filed Friday in federal court in Philadelphia, adds to controversy over electric tissue-cutting "morcellators. " The devices let doctors remove tissue through tiny abdominal incisions, shortening patients' hospitalization and recovery. In rare cases, the process can disseminate an aggressive uterine cancer, leiomyosarcoma, that routine diagnostic tests usually miss.
November 23, 2012 |
NEW YORK - If you've ever fired up your computer and cringed in anticipation of what nasty e-mails await, pity Eve Ensler. The Tony Award-winning playwright and activist gets a daily record sent to her of atrocities against women - a never-ending drumbeat of rape, genital mutilation, imprisonment, and murder. "In my inbox on any given day, I can tell you every single story of any violation that's happening to women anywhere in the world," Ensler says. "It's horrifying. My inbox is like a nightmare.
August 2, 2012 |
One year after my mother's hysterectomy for uterine cancer, a scan taken in July 2011 showed two small spots in the pelvic region that were most likely the return of her cancer. She received the news on her 84th birthday. Her doctor recommended a biopsy and then 18 weeks of chemotherapy treatments, followed by radiation. She would lose her hair, she might struggle with nausea, and the radiation held some risks due to other organs in the pelvic area. Sitting with my mother in an office in New York City, across the desk from her oncologist, I heard her say, in a calm and confident voice: "I don't want any further treatment.
February 6, 2012 |
Question: My 41-year-old daughter was diagnosed with breast cancer at an early stage. She opted for a bilateral mastectomy and chemotherapy. There was some lymph-node involvement. Her doctor is now trying to talk her into five years of Tamoxifen. I worry about the side effects like cataracts, stroke, aneurysm, and uterine cancer. Isn't a bilateral mastectomy followed by chemo enough? Answer: Research shows that using the anti-estrogen drug Tamoxifen in women who have had breast cancer reduces the chance that the breast cancer will return by up to 50 percent.
March 16, 2009 |
Curtis Opera Theatre's production of Wozzeck rolled onto the Perelman Theater stage Friday with such unstoppable momentum that the temptation was to duck - as though that would offer protection from the merciless glare of its awful truth. So it is with this masterpiece of German expressionism: awful becomes awe-ful. Though this wasn't the most penetrating encounter I've had with Alban Berg's opera, Curtis' production (in collaboration with the Opera Company of Philadelphia and the Kimmel Center)